ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Texas House of Representatives Passes Bill to End “Archaic” Tampon Tax

New York, NY (Newsworthy.ai) Wednesday Mar 29, 2023 @ 11:20 AM Pacific —

Texas collects almost $30 million annually—far more than any other state—on the sale of period products, a practice the Comptroller has called “archaic.” This session, the end of this practice is in sight. Texas’ actions may help bring about the end of the tampon tax in the 21 additional states where it still exists.

Governor Abbott (R), Comptroller Glenn Hegar, and Senator Joan Huffman (R) have all voiced support for ending the tampon tax. Hegar called the taxing of these items “archaic” and said it’s time “to rectify this issue.” Huffman acknowledged these products are “not optional” and “essential to women’s health and well-being.”

Bipartisan House Bill 300 exempts menstrual products from tax, along with diapers, baby bottles, breastfeeding devices, maternity clothing, and other "family care products."

Period Law, the nonprofit group of lawyers dedicated to ending the tampon tax nationally since 2016, celebrates HB300 sponsor Representative Donna Howard (D), who has introduced tampon tax repeal bills every session since 2017. Period Law has been working on this issue in Texas since that time, too, including through its 2019 Tampon Tax Protest, which flooded the Comptroller’s office with demands for tax refunds.

“Texas should’ve never taxed these items to begin with,” said Period Law Executive Director Laura Strausfeld, noting that Texas exempts bandaids, incontinence pads, sunscreen, and many other items from sales tax. “It took protests, a lawsuit, and a deeply dark moment for women’s health in Texas to get us to this point, but we nonetheless enthusiastically celebrate this rare bipartisan win for Texas women.”

Period Law is partnering with the youth-powered nonprofit PERIOD. and CVS Health to eliminate the unfair sales tax on period products in the remaining 22 states. In Texas, the law firm Baker Botts has filed a lawsuit challenging the tax as unconstitutional. With the assistance of volunteer attorneys from around the country, including a core team from WilmerHale, Period Law has helped reduce the number of “tampon-taxing” states from 40 in 2016 to 22 today.

Period Law, PERIOD., and other advocacy and legal partners are working to make significant progress this session. Already, seven states have held hearings on tampon tax repeal this year. In Arizona as well as Texas, exemption has passed the House. Just one day after HB300 was passed by oral vote in Texas, South Carolina’s Ways and Means Committee passed their version. In Georgia and South Dakota - where HB1159 was the first repeal bill ever introduced - young female legislators led spirited debates and presented moving testimony about periods in majority-male rooms.

Menstrual products are medically necessary. The FDA categorizes them as Class I and Class II medical devices. The CARES Act allows reimbursement of menstrual care products as qualified medical expenses through various tax-advantaged accounts (HSAs, Archer MSAs, Health FSAs, and HRAs).

“It’s time to prioritize women’s health and change antiquated policies that are being overlooked because representation at “the table” isn’t reflective of the demographic composition of our society,” stated Lisa White, Director of Strategy & Operations for Period Law.

For more information, please contact suzanne@periodlaw.org or visit our website, periodlaw.org.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News at the speed of influence™. Reference URL for this press release is here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.